126 related articles for article (PubMed ID: 8375257)
21. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
22. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
23. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
[TBL] [Abstract][Full Text] [Related]
24. Detection of urinary MCP-1 in patients with diabetic nephropathy.
Saitoh A; Sekizuka K; Hayashi T; Kaneko S; Suzuki Y; Tomino Y
Nephron; 1998 Sep; 80(1):99. PubMed ID: 9730720
[No Abstract] [Full Text] [Related]
25. Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy.
Suzuki K; Souda S; Ikarashi T; Kaneko S; Nakagawa O; Aizawa Y
Diabetes Res Clin Pract; 2002 Sep; 57(3):179-83. PubMed ID: 12126767
[TBL] [Abstract][Full Text] [Related]
26. Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Daimon M; Ono Y; Saito T; Yamaguchi H; Hirata A; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Kato T
Diabetes Care; 1999 May; 22(5):877-8. PubMed ID: 10332715
[No Abstract] [Full Text] [Related]
27. Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy.
Shindo H; Tawata M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
Diabetes Res Clin Pract; 1993; 21(2-3):115-22. PubMed ID: 7505737
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
[TBL] [Abstract][Full Text] [Related]
29. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy.
Taniwaki H; Ishimura E; Matsumoto N; Emoto M; Inaba M; Nishizawa Y
Diabetes Care; 2001 Sep; 24(9):1653-60. PubMed ID: 11522715
[TBL] [Abstract][Full Text] [Related]
30. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
Romero R; Salinas I; Lucas A; Abad E; Reverter JL; Johnston S; Sanmarti A
Diabetes Care; 1993 Apr; 16(4):597-600. PubMed ID: 8462386
[TBL] [Abstract][Full Text] [Related]
31. Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.
Deckert T; Kofoed-Enevoldsen A; Vidal P; Nørgaard K; Andreasen HB; Feldt-Rasmussen B
Diabetologia; 1993 Mar; 36(3):244-51. PubMed ID: 8462774
[TBL] [Abstract][Full Text] [Related]
32. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
[TBL] [Abstract][Full Text] [Related]
33. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
Torffvit O; Agardh CD
J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for retardation of renal function in IDDM and NIDDM with nephropathy.
Hara S; Arizono K; Ubara Y; Morita T; Suzuki Y; Ogura Y; Hagura R; Akanuma Y
J Diabet Complications; 1991; 5(2-3):131-3. PubMed ID: 1770020
[TBL] [Abstract][Full Text] [Related]
35. Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus.
Chiasera JM; Ward-Cook KM; McCune SA; Wardlaw GM
Ann Clin Lab Sci; 2000 Oct; 30(4):346-53. PubMed ID: 11045758
[TBL] [Abstract][Full Text] [Related]
36. Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate.
Kawasaki I; Hiura Y; Tamai A; Yoshida Y; Yakusiji Y; Ikuno Y; Okada M; Ueno H; Tanaka N; Yamagami K; Fukumoto M; Hosoi M
J Diabetes; 2015 Jan; 7(1):41-6. PubMed ID: 24661437
[TBL] [Abstract][Full Text] [Related]
37. Analysis on influencing factors of abnormal renal function in elderly patients with type 2 diabetes mellitus.
Chai T; Zhang D; Li Z
Minerva Endocrinol; 2020 Mar; 45(1):12-17. PubMed ID: 29652115
[TBL] [Abstract][Full Text] [Related]
38. The effects of calcitriol on albuminuria in patients with type-2 diabetes mellitus.
Bonakdaran S; Hami M; Hatefi A
Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1215-20. PubMed ID: 23168851
[TBL] [Abstract][Full Text] [Related]
39. Hyperinsulinemia in type II diabetic patients with microalbuminuria.
Trevisan R; Orrasch M; Jori E; Tiengo A
Diabetes Care; 1993 Aug; 16(8):1211. PubMed ID: 8375255
[No Abstract] [Full Text] [Related]
40. One-day survey of albuminuria in diabetic outpatients in Fukuoka Prefecture, Japan. Fukuoka Diabetic Clinic Group.
Nomiyama R; Nunoi K; Tsutsu N; Satho Y; Yoshizumi H; Himeno H; Nakamura Y; Fujishima M
J Diabet Complications; 1991; 5(2-3):155-6. PubMed ID: 1770029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
